Chemokine Regulation During Epidemic Coronavirus Infection

Overview

Journal Front Pharmacol

Date 2021 Feb 22

PMID 33613280

Citations 8

Authors

Shamik Majumdar

Philip M Murphy

Affiliations

Soon will be listed here.

Abstract

SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus-2) is the third coronavirus to emerge as a cause of severe and frequently fatal pneumonia epidemics in humans, joining SARS-CoV and MERS-CoV (Middle East Respiratory Syndrome-coronavirus). As with many infectious diseases, the immune response to coronavirus infection may act as a double-edged sword: necessary for promoting antiviral host defense, but, if not appropriately regulated, also able to incite life-threatening immunopathology. Key immunoregulatory mediators include the chemokines, a large family of leukocyte chemoattractants that coordinate leukocyte infiltration, positioning and activation in infected tissue by acting at specific G protein-coupled receptors. Here, we compare the involvement of chemokines and chemokine receptors during infection with the three epidemic coronaviruses and discuss their potential value as biomarkers and targets for therapeutic development.

Citing Articles

Cxcl10 is required for survival during SARS-CoV-2 infection in mice.

Majumdar S, Weaver J, Pontejo S, Minai M, Lu X, Gao J bioRxiv. 2025; .

PMID: 39803542 PMC: 11722219. DOI: 10.1101/2024.09.30.613319.

Dual spatially resolved transcriptomics for human host-pathogen colocalization studies in FFPE tissue sections.

Sounart H, Lazar E, Masarapu Y, Wu J, Varkonyi T, Glasz T Genome Biol. 2023; 24(1):237.

PMID: 37858234 PMC: 10588020. DOI: 10.1186/s13059-023-03080-y.

Cysteine-cysteine Chemokine Receptor Type 5 Plays a Critical Role in Exercise Performance by Regulating Mitochondrial Content in Skeletal Muscle.

Chen C, Chen L, Chung Y, Liu S, Chen S, Chang Y Inflammation. 2023; 46(6):2089-2101.

PMID: 37436644 DOI: 10.1007/s10753-023-01864-9.

Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice.

Pastor-Fernandez A, Bertos A, Sierra-Ramirez A, Del Moral-Salmoral J, Merino J, de Avila A Aging Cell. 2023; 22(3):e13771.

PMID: 36704839 PMC: 10014049. DOI: 10.1111/acel.13771.

COVID-19-specific transcriptomic signature detectable in blood across multiple cohorts.

Valikangas T, Junttila S, Rytkonen K, Kukkonen-Macchi A, Suomi T, Elo L Front Genet. 2022; 13:929887.

PMID: 35991542 PMC: 9388772. DOI: 10.3389/fgene.2022.929887.

References

Arabi Y, Balkhy H, Hayden F, Bouchama A, Luke T, Baillie J . Middle East Respiratory Syndrome. N Engl J Med. 2017; 376(6):584-594. PMC: 5362064. DOI: 10.1056/NEJMsr1408795. View

Tsang K, Ho P, Ooi G, Yee W, Wang T, Chan-Yeung M . A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003; 348(20):1977-85. DOI: 10.1056/NEJMoa030666. View

de Wit E, Rasmussen A, Falzarano D, Bushmaker T, Feldmann F, Brining D . Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques. Proc Natl Acad Sci U S A. 2013; 110(41):16598-603. PMC: 3799368. DOI: 10.1073/pnas.1310744110. View

Cameron M, Ran L, Xu L, Danesh A, Bermejo-Martin J, Cameron C . Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol. 2007; 81(16):8692-706. PMC: 1951379. DOI: 10.1128/JVI.00527-07. View

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View

Barton L, Duval E, Stroberg E, Ghosh S, Mukhopadhyay S . COVID-19 Autopsies, Oklahoma, USA. Am J Clin Pathol. 2020; 153(6):725-733. PMC: 7184436. DOI: 10.1093/ajcp/aqaa062. View

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

Jiang Y, Xu J, Zhou C, Wu Z, Zhong S, Liu J . Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome. Am J Respir Crit Care Med. 2005; 171(8):850-7. DOI: 10.1164/rccm.200407-857OC. View

Kuri T, Zhang X, Habjan M, Martinez-Sobrido L, Garcia-Sastre A, Yuan Z . Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. J Gen Virol. 2009; 90(Pt 11):2686-2694. PMC: 2888313. DOI: 10.1099/vir.0.013599-0. View

10.

Channappanavar R, Fehr A, Zheng J, Wohlford-Lenane C, Abrahante J, Mack M . IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes. J Clin Invest. 2019; 129(9):3625-3639. PMC: 6715373. DOI: 10.1172/JCI126363. View

11.

Patterson B, Seethamraju H, Dhody K, Corley M, Kazempour K, Lalezari J . CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. Int J Infect Dis. 2020; 103:25-32. PMC: 7654230. DOI: 10.1016/j.ijid.2020.10.101. View

12.

Booth C, Matukas L, Tomlinson G, Rachlis A, Rose D, Dwosh H . Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003; 289(21):2801-9. DOI: 10.1001/jama.289.21.JOC30885. View

13.

Nicholls J, Butany J, Poon L, Chan K, Beh S, Poutanen S . Time course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS. PLoS Med. 2005; 3(2):e27. PMC: 1324951. DOI: 10.1371/journal.pmed.0030027. View

14.

Law A, Lee D, Cheung B, Yim H, Lau A . Role for nonstructural protein 1 of severe acute respiratory syndrome coronavirus in chemokine dysregulation. J Virol. 2006; 81(1):416-22. PMC: 1797241. DOI: 10.1128/JVI.02336-05. View

15.

Ksiazek T, Erdman D, Goldsmith C, Zaki S, Peret T, Emery S . A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003; 348(20):1953-66. DOI: 10.1056/NEJMoa030781. View

16.

Smits S, van den Brand J, de Lang A, Leijten L, van IJcken W, van Amerongen G . Distinct severe acute respiratory syndrome coronavirus-induced acute lung injury pathways in two different nonhuman primate species. J Virol. 2011; 85(9):4234-45. PMC: 3126247. DOI: 10.1128/JVI.02395-10. View

17.

Huang K, Su I, Theron M, Wu Y, Lai S, Liu C . An interferon-gamma-related cytokine storm in SARS patients. J Med Virol. 2004; 75(2):185-94. PMC: 7166886. DOI: 10.1002/jmv.20255. View

18.

Ellinghaus D, Degenhardt F, Bujanda L, Buti M, Albillos A, Invernizzi P . Genomewide Association Study of Severe Covid-19 with Respiratory Failure. N Engl J Med. 2020; 383(16):1522-1534. PMC: 7315890. DOI: 10.1056/NEJMoa2020283. View

19.

Law H, Cheung C, Sia S, Chan Y, Peiris J, Lau Y . Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells. BMC Immunol. 2009; 10:35. PMC: 2700820. DOI: 10.1186/1471-2172-10-35. View

20.

Garbati M, Fagbo S, Fang V, Skakni L, Joseph M, Wani T . A Comparative Study of Clinical Presentation and Risk Factors for Adverse Outcome in Patients Hospitalised with Acute Respiratory Disease Due to MERS Coronavirus or Other Causes. PLoS One. 2016; 11(11):e0165978. PMC: 5094725. DOI: 10.1371/journal.pone.0165978. View